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The Frequency of IgA Nephropathy at a Single Center in Pakistan 
S. Muzaffar, N. S. Azad, N. Kayani, S. Pervaz, A. Ahmed*, S. H. Hasan
Departments of Pathology and Medicine*, The Aga Khan University Hospital, Karachi.
Abstract
Objective: To detect the prevalence of IgA nephropathy in Pakistani patients, as no significant published data
from this part of the developing world is available in the international literature for reference.
Material And Method: The study was conducted in a university hospital on 105 consecutive renal biopsy spec-
imens. Direct immunofluorescence microscopy was performed using antibodies specific for the heavy chains of
IgG, IgA, IgM, C3 and fibrinogen. 
Results: Seventy-nine (79) cases were classified as glomerulopathies, out of which 10 cases (12.65%) were
diagnosed as IgA nephropathy, among which one case was that of Henoch- Schonlein purpura. The age range
was 6 to 65 years with median age of 25 years and male to female ratio was 1.5: 1. Nephrotic range proteinuria
was seen in 40% of cases and 50% cases showed impaired renal function. The light microscopic examination
revealed diffuse proliferative pattern in 3 cases out of which one case showed crescent formations. Focal-seg-
mental glomerulosclerosis, minimum histologic lesion and advanced chronic glomerulonephritic patterns were
observed in 2 cases each and in one case focal proliferative morphology was appreciated. 
Conclusion:The frequency of IgA nephropathy among glomerular diseases was 12.65% in our study, which is
somewhat higher when comparing the studies from North America, United Kingdom and Northwest Europe.
However, it was significantly lower when comparing the studies from other parts of Asia (JPMA 53:301;2003).
Introduction
IgA nephropathy, also known as Berger's disease
has great degree of geographical variation in terms of
incidence. Its incidence has been reported as low as 2%
to as high as 52% in various studies from different parts
of the world. The recognition of this entity is principal-
ly based on its characteristic clinical presentation and
pathological findings. Clinically, in most of the cases, it
is presented as recurrent episodes of macroscopic hema-
turia, persistent microscopic hematuria with mild to
moderate proteinuria. Pathologically, it is characterized by
focal glomerulonephritis with predominant IgA deposits
in glomeruli. The prevalence of IgA nephropathy has not
been widely studied in Pakistani population, especially
belonging to the southern part. Pakistan is a developing
country of South Asia with a population of about 140
million. The purpose of this study was to identify the
prevalence of IgA nephropathy in this part of the world.
Subjects and Methods
A total of 105 consecutive biopsies were includ-
ed in this study (from 1998 to April 2001). The cases
with inadequate biopsy specimens either for light or
immunofluorescence microscopy, were excluded from
the study. Two separate cores of renal tissue were
obtained for histological and immunofluorescence stud-
ies. As facility for electron microscopy (EM) was not
available, so sample was not submitted in EM fixative. 
For histological evaluation, the biopsy specimens
were fixed in 10% buffered formalin, processed routine-
embedded in paraffin and cut at 4 um thickness. The sec-
tions were stained with hematoxylin and eosin (H&E), periodic
acid Schiff (PAS), Masson trichrome and Gomori methamine sil-
ver (GMS). The glomerular lesions in IgA nephropathy were
graded according to Haas classification.1
Fresh and unfixed biopsy specimens were obtained for
immunofluorescence microscopy immediately transported to the
laboratory and were frozen either in cryostat or in liquid nitro-
gen. Cryostat sections were cut at 5 um for direct immunofluo-
rescence microscopy and incubated with antibodies specific for
the heavy chains of IgG, IgA, IgM, C3 and fibrinogen. The
intensity of fluorescence was graded on a scale of 0 to 4; 0 being
negative and +4 for maximum intensity.
Results
Based on histological and immunofluorescence studies
performed in 105 consecutive biopsy specimens, 79 cases
(75.2%) were classified as glomerular diseases including both
primary and secondary; in 21 cases there was the suggestion of
minimal change disease; 11 cases had diffuse proliferative
glomerulonephritis; 11 cases had membranous glomerulopathy;
10 cases were lupus nephritis, 5 cases had focal proliferative
glomerulonephritis, and 5 cases showed crescentic glomeru-
lonephritis. In 6 cases focal and segmental glomerulosclerosis
was appreciated. Ten cases were diagnosed as IgA nephropathy
among which one case was that of Henoch-Schonlein purpura
(Table 1). Sixteen cases (15.2%) showed interstitial nephritis; 5
cases had end stage kidney disease showing 
Table 1. Patients with glomerular diseases (n=79).
S.No. Pathological diagnosis No. of %  of 
patients all patients
1 Minimal change disease 21 26.6
2 Diffuse proliferative GN 11 13.9
3 Membranous GN 11 13.9
4 IgA nephropathy 10 12.6
5 Lupus Nephritis 10 12.6
6 Focal segmental glomerulosclerosis 6 7.6
7 Focal proliferative GN 5 6.3
8 Crescentic GN 5 6.3
Table 2. Clinical profile of patients with IgA nephropathy.
S. No Proteinuria Hematuria S. Creatinine CRF Others
(gm/24hrs) mg/dl
1 >3.5gm Macroscopic NA NA -
2 1-2 gm Microscopic 1.9mg NA Highblood pressure, edema, 
ANCA-ve, BUN* 116 mg/dl
3 >3.5gm Microscopic 2.2mg + NA
4 Unknown NA NA + NA
5 1.2gm NA 4.9gm NA High blood pressure
6 NA NA NA + NA
7 >3.5gms NA NA NA NA
8 Non-Nephrotic Microscopic NA NA NA
9 >3.5gm NA NA NA NA
10 Non-nephrotic Microscopic NA NA Failure to thrive, loose motions, 
fever, abdominal pain and skin rash.
CRF = Chronic renal failure,     NA = Not available ANCA = Antineutrophilic cytoplasmic autoantibody BUN = Blood urea nitrogen
Table 3. Histopathologic and immunofluorescence profile of IgA
nephropathy.
S. No. Haas Grading IF Combinations
1 Diffuse proliferative GN, Class IV IgA only
2 Crescentic GN, Class IV IgA and C3
3 Focal-segmental glomerulosclerosis, Class II IgA and C3
4 Advanced chronic GN, Class V IgA only
5 Focal proliferative GN, Class III IgA, C3 and Fib.
6 Advanced chronic GN, Class V IgA and C3
7 Minimal histologic lesion, Class I IgA and C3
8 Focal-segmental glomerulosclerosis, Class II IgA, IgM and C3
9 Diffuse proliferative GN, Class IV IgA, IgM and 
Fib.
10 Minimal histologic lesion, Henoch-Schonlein IgA and IgG
purpura, Class I
global glomerulosclerosis; 2 cases had amyloido-
sis and one each had diabetic and hypertensive nephropa-
thy and acute tubular necrosis. The patients with IgA
nephropathy showed an age range of 6 to 65 years with a
mean age of 31.7 years. The male to female ratio was
1.5:1. The clinical, pathological and immunofluorescence
features are summarized in the tables 2 and 3. The pattern
of immune deposits revealed exclusive IgA immunoglob-
ulin in 2 cases (20%); IgA with C3 in 5 cases (50%); IgM
or IgG were  co-deposited in 20% and 10% of cases,
respectively. Fibrin deposits were observed in 2 cases
(20%). On light microscopic examination 3 cases revealed
diffuse proliferative pattern with one case showing crescent
formations; 2 cases, each of focal-segmental glomeruloscle-
minimum histologic lesion and advanced chronic glomeru-
lonephritis were observed, while one case revealed focal prolif-
erative morphology.
Discussion
IgA nephropathy is recognized as the most prevalent form of
primary glomerulonephritis worldwide and a major cause of
end-stage kidney disease and chronic renal insufficiency. The
frequency of IgA nephropathy reported in the international liter-
ature varies widely from as low as 2% to as high as 52%.  This
variation shows a definite geographic pattern, as 5% to 10%
frequency was reported from North America, United Kingdom,
and northwestern Europe, 20% to 35% in most European series
and 25% to 52% in studies from Asian countries.2-41 The high-
est prevalence in Asia was reported from Singapore and
Japan10,21 while in Europe, the prevalence rate was highest in
Italy and France22,39 (Table 4). This highly variable geographic
variation is attributable to many factors including institutional
policy for renal biopsy, ethnic and racial factors.
Table 4. Prevalence of IgA nephropathy in different countries.
Country No. of patients Author % of IgA nephropathy
Korea 166 Kim D.19986 25.98
2361 Choi IJ et al.19917 17.8
250 Yoshikawa et al. 19918 41.2
657   (Children) Ko et al.19879 58    with hematuria
Japan 201 Yoshikama et al.19918 31.3
1063 Koyama et al.199710 47.2
1043 Maeda et al.199511 28
China 190   (Children) Lai et al.198712 16
Pakistan 102 Khan et al.198813 5.9
50 Khan et al.199014 2
238 Lakhnana et al.199415 7.9
105 Present study 12.6
India 106 Sehgal et al.199516 10.37
1146 Bhayan et al. 1992 17 7.24
238   (IF done) Data et al. 198718 4.2
Bangladesh 42 Sharmin et al. 199719 11.9
Singapore - Sinniah et al. 198120 20
- Woo et al 21 52
Italy 12040 Italian registry of renal 
bx (1987-95)22 35.9
1926 Stratta et al.199623 26
- D'Amico. 1983 24 25
England - Sissons et al. 197525 4
- Davison. 198426 10
- Ballardie et al. 198727 7.1  (1972-78) and 21.1 (1979-86)
Saudi Arabia 200 Mitwalli et al. 200028 10.2
166 Al Homrany. 199929 18.9
782 Huraib et al. 200030 6.5
300 Abdurrehman. 198431 3
Jordan 350 Said et al. 200032 9.5
179 Ghnaimat. 199933 3.35
Egypt 1234 Barsoum et al. 200034 9.8
South Africa 252 Blacks and and 75 Indian Seedat et al. 198835 0.7 in Blacks and 13.3 in Indians
United States - Hood et al.198136 4.6
- McCoy et al. 197437 4.3
Canada - Katz et al. 197638 9.5
France - Simon et al.198439 30.1
- Droz et al. 197640 22
Tunisia - Hachicha et al. 199241 3.8
It is well known that the incidence and preva-
lence of IgA nephropathy largely depends on the policy
used in performing the renal biopsy in patients with per-
sistent microscopic hematuria and in subjects with
recurrent gross hematuria with normal renal function.
The importance of biopsy policy is highlighted by the
example of increased frequency of IgA nephropathy
reported from United Kingdom. In two earlier studies the fre-
quency of IgA nephropathy was reported to be 4% and 10% in the
UK.25,26 In a more recent study, the authors noted that the disease
was detected in 7.1% of biopsies during 1972 to 1986 whereas
the frequency for 1979 to end-1986 was 21.1%. 
The authors concluded that the apparent increase was
predominantly a result of an increase in the absolute number
of patients with IgA nephropathy presenting with microscop-
ic hematuria and proteinuria, with little change in the inci-
dence of those with episodic macroscopic hematuria. They
also suggested that the true disease incidence may be greater
than previously suspected, and comparable with that in the
countries reporting the highest detection rates and hence sup-
porting the earlier suggestion of Power et al that IgA
nephropathy is not rare in the UK.27,42 Racial differences cer-
tainly play some role in the prevalence of IgA associated
nephropathies. In a study from Alabama, USA, the authors
have reported a strikingly low prevalence of IgA nephropa-
thy in Blacks as compared to Whites (1 Black and 21 whites)
This study was comparable with other studies from USA.43,44
In another study from South Africa, which included 252
Blacks and 75 Indians, the authors found a very low preva-
lence rate of IgA nephropathy in Blacks (0.7%) as compared
to Indian residents (13.3%) in South Africa.35 These obser-
vations regarding the racial distribution support the role of
familial predisposition in prevalence of IgA nephropathy.
The prevalence of IgA nephropathy has not been
studied widely in Pakistani patients and some of data is
available in the local journals, and therefore is not accessible
for international reference.   In 2 studies from southern part
of the country, it was reported to be 2%, which was carried
out in 50 cases with application of immunoperoxidase tech-
nique and 5.9%, which was conducted on 102 cases.13,14 In
another study from northern part of Pakistan, the prevalence
of IgA nephropathy was reported to be 7.9% out of 238 cases
with glomerulonephritis.15 Here, it would be worth mention-
ing that at present there are no set criteria regarding the renal
biopsy policy. It varies from nephrologist to nephrologist and
unfortunately the facility of immunofluorescence
microscopy is available only in few centers, therefore many
nephrologists are usually reluctant to do biopsy in patients
with clinical suspicion of IgA nephropathy especially with
normal renal functions.  
Hematuria is the most common and consistent mani-
festation of IgA nephropathy and is seen in more than 95%
of patients as the presenting manifestation. Episodic gross
hematuria and persistent microhematuria occur in approxi-
mately 54% and 78% of patients, respectively. The incidence
of gross hematuria in children is higher (80%) than in adults
(45%) in Western population, while in the Eastern countries
the incidence of macrohematuria is same in  the two groups
i.e., 40%. Most of the cases are associated with mild to mod-
erate proteinuria and rarely the nephrotic syndrome. In small
percentage of cases, hypertension, acute renal failure and
chronic renal failure were observed. The age range of the
patients with IgA nephropathy was 4 to 80 years with a mean age
of 28 years. The male to female ratio was 2:1.45-51
In this study 4 cases (40%) presented with nephrotic syn-
drome, which was unusual as nephrotic range proteinuria is unusu-
ally seen in patients with IgA nephropathy. On light microscopic
examination 2 of these cases showed diffuse proliferative pattern
and in one case the patient also had gross hematuria. One case with
focal segmental glomerulosclerotic pattern and surprisingly one
case with minimal glomerular lesion also showed nephrotic range
protienuria. In general, patients with heavy proteinuria have the
most severe glomerular lesions and the least favorable prognosis,
however, a subset of patients with minimal glomerular lesions
have been found to be associated with nephrotic range protienuria.
Two cases that presented with chronic renal failure revealed mor-
phological features of advanced chronic glomerulonephritis (Haas
class V). Gross hematuria was detected in only one patient with a
diffuse proliferative pattern in an adolescent female. Microscopic
hematuria was the presenting feature in 3 cases. History of hema-
turia was not recorded in 6 cases. Five cases (50%) showed
impaired renal functions out of which histological examination of
2 cases revealed advanced chronic GN (Haas V) pattern while one
case each of focal segmental glomerusclerosis (Haas II), focal pro-
liferative GN (Haas III) and crescentic GN (Haas IV).  
In conclusion, the frequency of primary IgA nephropathy
was found to be 12.65% in our series of patients. The difference in
prevalence from other local studies is probably related to the sam-
ple size and possibly the biopsy policy in different institutions. We
feel that larger studies are required to establish the exact preva-
lence of IgA nephropathy in this country.
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